Celularity Stock Fundamentals
| CELUW Stock | USD 0.02 0 5.29% |
Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.
At this time, Celularity's Depreciation And Amortization is fairly stable compared to the past year. EBIT is likely to climb to about 17.2 M in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024. Celularity | Select Account or Indicator |
Celularity Company Operating Margin Analysis
Celularity's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Celularity Operating Margin | (0.84) % |
Most of Celularity's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celularity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Celularity Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Celularity has an Operating Margin of -0.8402%. This is 97.6% lower than that of the Biotechnology sector and 99.25% lower than that of the Health Care industry. The operating margin for all United States stocks is 84.75% lower than that of the firm.
Celularity Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Celularity's current stock value. Our valuation model uses many indicators to compare Celularity value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Celularity competition to find correlations between indicators driving Celularity's intrinsic value. More Info.Celularity is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . At this time, Celularity's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Celularity by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Celularity Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celularity's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celularity could also be used in its relative valuation, which is a method of valuing Celularity by comparing valuation metrics of similar companies.Celularity is currently under evaluation in operating margin category among its peers.
Celularity Fundamentals
| Return On Equity | -1.54 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (2.64) % | ||||
| Operating Margin | (0.84) % | ||||
| Number Of Shares Shorted | 168.34 K | ||||
| Revenue | 22.77 M | ||||
| EBITDA | (35.91 M) | ||||
| Net Income | (196.29 M) | ||||
| Cash And Equivalents | 38 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 39.24 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | 1.27 X | ||||
| Cash Flow From Operations | (38.69 M) | ||||
| Earnings Per Share | (0.87) X | ||||
| Number Of Employees | 120 | ||||
| Beta | 0.51 | ||||
| Total Asset | 143.89 M | ||||
| Retained Earnings | (841.79 M) | ||||
| Working Capital | (47.51 M) | ||||
| Net Asset | 143.89 M |
About Celularity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2 M | 2.5 M | |
| Total Revenue | 22.8 M | 21.5 M | |
| Cost Of Revenue | 16 M | 12.4 M | |
| Stock Based Compensation To Revenue | 0.66 | 0.55 | |
| Sales General And Administrative To Revenue | 2.22 | 1.82 | |
| Research And Ddevelopement To Revenue | 1.34 | 2.31 | |
| Capex To Revenue | 0.18 | 0.17 | |
| Revenue Per Share | 1.28 | 1.21 | |
| Ebit Per Revenue | (8.44) | (8.02) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.